Hydrocortisone, Iodoquinol Cream
NDC Package 52187-532-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is approaching its end of marketing date. An upcoming end of marketing date means the product has been delisted but will remain in the NDC database until the end of marketing date is reached. In most cases, the FDA advises firms to use the expiration date of the last lot produced as the end marketing date, reflecting the possibility that the product may still be available even after manufacturing has stopped.

Hydrocortisone, Iodoquinol cream is based on a review of a related drug by the National Research Council and subsequent FDA classification for that drug, the indications are as follows: “Possibly” Effective: Contact or atopic dermatitis; impetiginized eczema; nummular eczema; endogenous chronic infectious dermatitis; stasis dermatitis; pyoderma; nuchal eczema and chronic eczematoid otitis externa; acne urticata; localized or disseminated neurodermatitis; lichen simplex chronicus; anogenital pruritus (vulvae, scroti, ani); folliculitis; bacterial dermatoses; mycotic dermatoses such as tinea (capitis, cruris, corporis, pedis); moniliasis; intertrigo. This formulation utilizes a cream delivery system. Marketed by Kmm Pharmaceuticals, Llc, this product is identified by NDC 52187-532.

Identification & Billing

NDC Package Code
52187-532-01
Package Description
1 TUBE in 1 CARTON / 28.4 g in 1 TUBE
Product Code
52187-532
11-Digit Billing Format
52187053201
Billing Unit
GM - Billing unit of "gram" is used when a product is measured by its weight.
Units Per Package
28.4 GM
RxNorm Crosswalk
  • RxCUI: 310870 - hydrocortisone 1 % / iodoquinol 1 % Topical Cream
  • RxCUI: 310870 - hydrocortisone 10 MG/ML / iodoquinol 10 MG/ML Topical Cream

Clinical Specifications

Proprietary Name
Hydrocortisone, Iodoquinol
Non-Proprietary Name
Hydrocortisone, Iodoquinol
Substance Name
Hydrocortisone; Iodoquinol
Dosage Form
Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Based on a review of a related drug by the National Research Council and subsequent FDA classification for that drug, the indications are as follows: “Possibly” Effective: Contact or atopic dermatitis; impetiginized eczema; nummular eczema; endogenous chronic infectious dermatitis; stasis dermatitis; pyoderma; nuchal eczema and chronic eczematoid otitis externa; acne urticata; localized or disseminated neurodermatitis; lichen simplex chronicus; anogenital pruritus (vulvae, scroti, ani); folliculitis; bacterial dermatoses; mycotic dermatoses such as tinea (capitis, cruris, corporis, pedis); moniliasis; intertrigo. Final classification of the less-than-effective indications requires further investigation.

Regulatory & Marketing

Labeler Name
Kmm Pharmaceuticals, Llc
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
10-16-2018
End Marketing Date
08-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 52187-532-01 identifies a specific commercial package of 1 tube in 1 carton / 28.4 g in 1 tube of Hydrocortisone, Iodoquinol, a human prescription drug labeled by Kmm Pharmaceuticals, Llc. This product is billed per "GM" gram and contains an estimated amount of 28.4 billable units per package. This cream is formulated for topical use and contains hydrocortisone; iodoquinol as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Kmm Pharmaceuticals, Llc on October 16, 2018.

How is this Kmm Pharmaceuticals, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 52187053201. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 28.4 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
52187-532-01
11-Digit CMS (5-4-2)
52187-0532-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.